Aggressive drug therapy in accelerated hypertension.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001014:Aortic Aneurysm / Q000209:etiology; D001927:Brain Diseases / Q000209:etiology; D002561:Cerebrovascular Disorders / Q000209:etiology; D003981:Diazoxide / Q000008:administration & dosage; D005292:Ferricyanides / Q000627:therapeutic use; D005665:Furosemide / Q000008:administration & dosage; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage; D006973:Hypertension / Q000150:complications; D006974:Hypertension, Malignant / Q000188:drug therapy* / Q000209:etiology; D006977:Hypertension, Renal / Q000209:etiology; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007668:Kidney / Q000187:drug effects; D007677:Kidney Function Tests; D012164:Retinal Diseases / Q000209:etiology; D014511:Uremia / Q000209:etiology
D000959:Antihypertensive Agents; D005292:Ferricyanides; D006830:Hydralazine; D005665:Furosemide; D003981:Diazoxide